| 注册
首页|期刊导航|临床与病理杂志|不同新辅助治疗方法联合手术治疗Ⅰb2/Ⅱa2期子宫颈鳞癌的效果分析

不同新辅助治疗方法联合手术治疗Ⅰb2/Ⅱa2期子宫颈鳞癌的效果分析

李宁 姚洪文 张蓉 李斌 李晓光 马绍康 吴令英

临床与病理杂志2017,Vol.37Issue(12):2595-2600,6.
临床与病理杂志2017,Vol.37Issue(12):2595-2600,6.DOI:10.3978/j.issn.2095-6959.2017.12.014

不同新辅助治疗方法联合手术治疗Ⅰb2/Ⅱa2期子宫颈鳞癌的效果分析

Effects of neoadjuvant therapies combined surgery on stage Ⅰb2/lla2 cervical squamous cell carcinoma

李宁 1姚洪文 1张蓉 1李斌 1李晓光 1马绍康 1吴令英1

作者信息

  • 1. 国家癌症中心/中国医学科学院,北京协和医学院肿瘤医院妇瘤科,北京100021
  • 折叠

摘要

Abstract

Objective:To compare the clinical efficacy and safety of neoadjuvant chemotherapy alone,neoadjuvant brachytherapy alone and combination of the two methods followed by radical surgery in patients with stage Ⅰb2/Ⅱa2 cervical squamous cell carcinoma.Methods:Between Jan,2001 and Dec,2013,324 patients with stage Ⅰb2/Ⅱa2 cervical squamous cell carcinoma received neoadjuvant therapy followed by radical hysterectomy and pelvic lymph node dissection +/-para-aortic lymph node dissection in Cancer Hospital,Chinese Academy of Medical Sciences.The patients were divided into 3 groups according to the methods of neoadjuvant therapy,neoadjuvant chemotherapy alone (NAC),neoadjuvant brachytherapy alone (B) and combination of the two methods (NAC+B).Response rate (complete response + partial response),postoperative risk factors,postoperative adjuvant therapy,and survival were respectively compared among 3 groups.SPSS 24.0 was used for statistical analysis.Results:The patient number of groups NAC,B and NAC+B was 109,90 and 125,respectively.The median follow up time was 57 months.There were no statistic difference regarding age,tumor grade and growth type of cervical tumor among 3 groups (P>0.05).No alopecia and grade 3/4 blood toxities was reported in group B.The frequency of grade 3/4 neutropenia and gastric-intestine adverse events was comparable between group NAC and NAC+B.There was no statistic difference of blood loss,surgery time and urinary injury among 3 groups.Response rates of NAC,B and NAC+B group were 55.0%,48.8% and 60.0%,respectively (P=0.270).The percentage of postoperative risk factors in NAC,B and NAC+B group were as follows:parametria invasion 0.9%,1.1% and 1.6%;positive margin 1.8%,1.1% and 0%;lymph node metastasis 22.0%,28.9% and 21.6%;lymph vascular space invasion (LVSI) 16.5%,12.2% and 12.8%;deep stromal invasion (DSI) 58.7%,55.6% and 51.2%,respectively (P>0.05).Among the groups of NAC,B and NAC+B,the percentage of postoperative radiation +/-chemotherapy were 57.8%,62.2% and 52.0% (P=0.317).The overall 5-year disease-free survival (DFS) and overall survival rates (OS) were 87.0% and 91.0%,respectively.Five-year DFS of these 3 groups were 92.0%,80.0% and 86.4%,respectively (P=0.056).Five-year OS of the 3 groups were 94.0%,85.6% and 92.0%,respectively (P=0.097).Conclusion:Patients with stage Ⅰb2/Ⅱa2 cervical squamous cell carcinoma received neoadjuvant therapy followed by radical surgery +/-postoperative radiation had good prognosis.There were no statistically significant differences of peri-operation complications,postoperative risk factors,DFS and OS among NAC,B and NAC+B groups.

关键词

宫颈癌/化疗/手术/新辅助化疗/近距离放疗

Key words

cervical cancer/chemotherapy/surgery/neoadjuvant therapy/brachytherapy

引用本文复制引用

李宁,姚洪文,张蓉,李斌,李晓光,马绍康,吴令英..不同新辅助治疗方法联合手术治疗Ⅰb2/Ⅱa2期子宫颈鳞癌的效果分析[J].临床与病理杂志,2017,37(12):2595-2600,6.

基金项目

中国医学科学院肿瘤医院科研课题(LC2012B38).This work was supported by the Clinical Research of Cancer Hospital,Chinese Academy of Medical Sciences,China (LC2012B38). (LC2012B38)

临床与病理杂志

OACSTPCD

1673-2588

访问量0
|
下载量0
段落导航相关论文